Clinical Trial Update: Selecting Hypoxic Tumours for Treatment Modification

View source ↗

Summary

A University of Manchester-sponsored clinical trial is exploring selecting hypoxic bladder cancer and prostate cancer tumors for treatment modification. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Prostate Cancer

Snippet

Sponsor: University of Manchester | Conditions: Bladder (Urothelial, Transitional Cell) Cancer, Prostate Cancer | Status: RECRUITING